CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-9.89%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.85B
AUM Growth
+$1.85B
(+5.4%)
Cap. Flow
+$374M
Cap. Flow
% of AUM
20.19%
Top 10 Holdings %
Top 10 Hldgs %
59.75%
Holding
37
New
9
Increased
14
Reduced
3
Closed
2
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$96.1M |
| 2 |
GSK
GSK
|
$76.4M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$58.4M |
| 4 |
Perrigo
PRGO
|
$46.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$43.7M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$93.3M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$62M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$52M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$27.4M |
| 5 |
Biogen
BIIB
|
$15M |
Sector Composition
| 1 | Healthcare | 95.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $208M | 9.86% | 2,800,000 -700,000 | -20% | -$52M |
|
2
Viatris
VTRS
$12.3B
| $137M | 6.5% | 5,000,000 +1,250,000 | +33% | +$34.3M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $134M | 6.34% | 1,000,000 +100,000 | +11% | +$13.4M |
|
4
Universal Health Services
UHS
$11.6B
| $105M | 4.98% | 900,000 | – | – |
|
5
McKesson
MCK
$85.4B
| $96.7M | 4.59% | 875,000 +125,000 | +17% | +$13.8M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $96.1M | 4.56% | +1,500,000 | New | +$96.1M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $92.4M | 4.38% | 2,250,000 +175,000 | +8% | +$7.18M |
|
|
8
Perrigo
PRGO
$3.27B
| $85.3M | 4.04% | 2,200,000 +1,200,000 | +120% | +$46.5M |
|
|
9
GSK
GSK
$79.9B
| $76.4M | 3.63% | +2,000,000 | New | +$76.4M |
|
|
10
Biogen
BIIB
$19.4B
| $75.2M | 3.57% | 250,000 -50,000 | -17% | -$15M |
|
11
Atara Biotherapeutics
ATRA
$84.6M
| $66M | 3.13% | 1,900,000 +280,000 | +17% | +$9.73M |
|
12
Nektar Therapeutics
NKTR
$568M
| $65.7M | 3.12% | 2,000,000 +500,000 | +33% | +$16.4M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $58.4M | 2.77% | +600,000 | New | +$58.4M |
|
14
Tenet Healthcare
THC
$16.3B
| $55.7M | 2.64% | 3,250,000 +1,700,000 | +110% | +$29.1M |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $50.3M | 2.39% | 2,800,000 +1,050,000 | +60% | +$18.9M |
|
16
Brookdale Senior Living
BKD
$1.83B
| $50.3M | 2.38% | 7,500,000 +1,000,000 | +15% | +$6.7M |
|
|
MNTA
17
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $44.2M | 2.1% | 4,000,000 +1,121,110 | +39% | +$12.4M |
|
|
18
Alnylam Pharmaceuticals
ALNY
$58.5B
| $43.7M | 2.08% | +600,000 | New | +$43.7M |
|
|
AMAG
19
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $40.3M | 1.91% | 2,650,000 | – | – |
|
|
MDCO
20
DELISTED
Medicines Co
MDCO
| $38.3M | 1.82% | 2,000,000 | – | – |
|
21
Sarepta Therapeutics
SRPT
$1.78B
| $38.2M | 1.81% | +350,000 | New | +$38.2M |
|
|
THOR
22
DELISTED
Synthorx, Inc. Common Stock
THOR
| $32.4M | 1.54% | +1,862,116 | New | +$32.4M |
|
23
Zymeworks
ZYME
$1.12B
| $31.8M | 1.51% | 2,166,000 +793,000 | +58% | +$11.6M |
|
|
24
HCA Healthcare
HCA
$94.5B
| $31.1M | 1.48% | 250,000 -750,000 | -75% | -$93.3M |
|
25
Puma Biotechnology
PBYI
$254M
| $26.5M | 1.26% | 1,300,000 +550,000 | +73% | +$11.2M |
|